NCT00589667 2014-04-02A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)Memorial Sloan Kettering Cancer CenterPhase 2 Completed26 enrolled 8 charts
NCT01057589 2013-09-18A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck CancerEli Lilly and CompanyPhase 2 Completed66 enrolled 11 charts